NCT03362112View on ClinicalTrials.gov

Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

1,713

Participants

Timeline

Start Date

January 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

June 1, 2017

Conditions

Type2 Diabetes

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT03362112 - Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter